Friday, 25 November 2016

Lancet study on statins was 'fundamentally flawed' critics say

Lancet study on statins was 'fundamentally flawed' critics say A major Lancet study which backed the safety of statins was “fundamentally flawed” and underestimated the side-effects of the heart drugs, a group of medics have said.

The research published in September concluded that the drugs help prevent around 80,000 major cardiovascular events, such as heart attacks or strokes, every year.

Scientists said the drugs did far more harm than good, with too many patients had been put off taking them because of needless fears about side-effects. The Daily Telegraph

See also:

No comments:

Post a Comment